Basic principles of clinical trials - What, how and why?

被引:0
|
作者
Unnebrink, K [1 ]
Pritsch, M [1 ]
机构
[1] Univ Heidelberg, Abt Med Biometrie, D-69120 Heidelberg, Germany
关键词
clinical trials; randomization; blinding; intention-to-treat;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Treatment evaluation is one of the most important tasks in medical research. Detailed standards have been developed during the last decades. The efficacy/effectiveness of treatments can only be assessed in comparison to control groups. To guarantee the internal validity of these comparisons, the groups have to be comparable at the beginning of the study. This can be achieved by randomized allocation of patients to treatment. Furthermore, as far as possible patient and physician should be blinded to treatment in order to avoid subjective influences on treatment results. Groups should still be comparable when analysing the trial, thus an analysis according to the principle of intention-to-treat ("as randomized") should be performed. These indispensable principles for design, conduct and analysis of clinical trials are widely accepted and contribute to reliable and credible results.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 50 条
  • [1] Basic principles of clinical trials - What, how and why?
    Unnebrink, K
    Pritsch, M
    MEDIZINISCHE KLINIK, 1999, 94 (08) : 458 - 464
  • [2] Grundprinzipien klinischer Therapiestudien — Was, wie und warum?Basic principles of clinical trials — What, how and why?
    Kristina Unnebrink
    Maria Pritsch
    Medizinische Klinik, 1999, 94 (8) : 458 - 464
  • [3] THE WHAT, WHY AND HOW OF BAYESIAN CLINICAL-TRIALS MONITORING
    FREEDMAN, LS
    SPIEGELHALTER, DJ
    PARMAR, MKB
    STATISTICS IN MEDICINE, 1994, 13 (13-14) : 1371 - 1383
  • [4] A tutorial on sensitivity analyses in clinical trials: the what, why, when and how
    Lehana Thabane
    Lawrence Mbuagbaw
    Shiyuan Zhang
    Zainab Samaan
    Maura Marcucci
    Chenglin Ye
    Marroon Thabane
    Lora Giangregorio
    Brittany Dennis
    Daisy Kosa
    Victoria Borg Debono
    Rejane Dillenburg
    Vincent Fruci
    Monica Bawor
    Juneyoung Lee
    George Wells
    Charles H Goldsmith
    BMC Medical Research Methodology, 13
  • [5] An introduction to multiplicity issues in clinical trials: the what, why, when and how
    Li, Guowei
    Taljaard, Monica
    Van den Heuvel, Edwin R.
    Levine, Mitchell A. H.
    Cook, Deborah J.
    Wells, George A.
    Devereaux, Philip J.
    Thabane, Lehana
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2017, 46 (02) : 746 - 755
  • [6] A tutorial on sensitivity analyses in clinical trials: the what, why, when and how
    Thabane, Lehana
    Mbuagbaw, Lawrence
    Zhang, Shiyuan
    Samaan, Zainab
    Marcucci, Maura
    Ye, Chenglin
    Thabane, Marroon
    Giangregorio, Lora
    Dennis, Brittany
    Kosa, Daisy
    Debono, Victoria Borg
    Dillenburg, Rejane
    Fruci, Vincent
    Bawor, Monica
    Lee, Juneyoung
    Wells, George
    Goldsmith, Charles H.
    BMC MEDICAL RESEARCH METHODOLOGY, 2013, 13
  • [7] THE WHAT, WHY AND HOW OF BAYESIAN CLINICAL-TRIALS MONITORING - DISCUSSION
    MACHIN, D
    STATISTICS IN MEDICINE, 1994, 13 (13-14) : 1385 - 1389
  • [8] SOME BASIC PRINCIPLES IN CLINICAL-TRIALS
    SEIGEL, D
    AMERICAN JOURNAL OF OPTOMETRY AND PHYSIOLOGICAL OPTICS, 1981, 58 (04): : 277 - 280
  • [9] Basic principles in the planning of clinical trials in surgical oncology
    Draxler W.
    Mittlb̈ock M.
    European Surgery, 2006, 38 (1) : 27 - 32
  • [10] Eco-Islam: Beyond the Principles of Why and What, and Into the Principles of How
    Dina M. Abdelzaher
    Amr Kotb
    Akrum Helfaya
    Journal of Business Ethics, 2019, 155 : 623 - 643